Dr Bernabeu will present the revolution of anti-mullerian hormone as a contraceptive and a means of delaying ovarian ageing at the Contraception Congress in Albacete
The Medical Director of Instituto Bernabeu, Dr Rafael Bernabeu, will participate in the 5th edition of the Contraception Congress organised by the Castilla La Mancha Contraception Society due to be held in Albacete on the 10th and 11th November. The Director of the Instituto Bernabeu Group, Dr Rafael Bernabeu, will cover the revolutionary discovery of the uses of anti-mullerian hormone in his speech entitled 'A new paradigm in contraception: AMH and derivatives.'
The gynaecologist will expand upon ongoing clinical studies on the effect of anti-mullerian hormone that have given favourable results in initial tests. The gynaecologist will disclose information that is set to be a revolution in the field of contraception therapies and that also demonstrates that, by retaining ovarian reserve, there is an impact in terms of delaying ovarian ageing and the menopause.